23750-0

Delete

Print full article

Companies partner to perform trials of antimicrobial topical treatment

A new company will be formed once the studies have been completed, which will have exclusive rights to manufacture, develop, and commercialize the treatments

Suggested Veterinary Products

Two health-care companies are collaborating to develop therapies for companion animal infections.

Stonehaven Incubate and antimicrobial protein specialist Lysando have agreed to jointly conduct proof-of-concept trials for topical treatments based on Artilysin, a new antimicrobial platform technology.

The technology was developed by Lysando to combat bacterial pathogens in a wide range of applications.

“Artilysin proteins can be designed to target specific pathogens whilst preserving the host’s natural microbiome, thus supporting the natural healing process and reducing side effects,” said Markus Count Matuschka de Greiffenclau, founder of Lysando.

“Importantly, there is no evidence pathogens can become immune to their action.”

The partners have agreed to form a new company once the studies are completed, which will have exclusive rights to manufacture, develop, and commercialize the treatments for skin, eye, and ear infections in dogs.

Leave a Comment

Comments

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.